LH inks new agreement to acquire BioReference Health's oncology and related clinical testing services businesses.

The independent laboratory company has entered an agreement to acquire BioReference Health's oncology diagnostic services.

Labcorp will acquire the oncology diagnostics operations from BioReference Health as part of a push to expand in high-growth ...

Labcorp Holdings has signed a deal to buy certain assets of OPKO Health's BioReference Health unit for up to $225 million. Labcorp on Tuesday said it will pay $192.5 million at closing for ...

Labcorp (LH) and OPKO Health (OPK) announced earlier on Tuesday that they have entered into an agreement for Labcorp to acquire select assets ...

Through this transaction, Labcorp will acquire BioReference Health's laboratory testing businesses focused on oncology and oncology-related clinical testing services across the United States.

Truist analyst David MacDonald notes Labcorp (LH) announced that the company has reached an agreement to acquire oncology-focused lab testing assets from BioReference Health (OPK) for $192.5M, with an ...

Laboratory Corporation Of America Holdings (NYSE:LH) acquires certain operations of Opko Health, Inc‘s (NASDAQ:OPK) subsidiary BioReference Health. The assets Labcorp is acquiring generate about ...

The deal is part of BioReference's ongoing effort to streamline its business to achieve profitability and follows the sale last year of clinical laboratory assets to Labcorp.

Labcorp (LH) and OPKO Health (OPK) announced that they have entered into an agreement for Labcorp to acquire select assets of BioReference ...

Labcorp has entered into an agreement to acquire select assets of BioReference Health, a wholly owned subsidiary of OPKO ...